ClinConnect ClinConnect Logo
Search / Trial NCT04813055

Prospective Registry Of Therapeutic EndoscopiC ulTrasound

Launched by PAOLO GIORGIO ARCIDIACONO, MD · Mar 23, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Endoscopic Ultrasound Therapeutic Eus Interventional Eus Biliary Drainage Gastro Jejunostomy Gallbladder Drainage Endoscopy

ClinConnect Summary

This clinical trial, called the Prospective Registry Of Therapeutic Endoscopic Ultrasound (T-EUS), is studying the long-term outcomes and success rates of a special procedure called therapeutic endoscopic ultrasound. This procedure helps treat various conditions affecting the digestive system, such as blockages in the stomach or bile ducts, fluid collections in the pancreas, and infections related to pancreatitis or gallbladder issues. By gathering information on patients who undergo this treatment, researchers hope to better understand which factors can lead to successful outcomes and potential complications, ultimately helping doctors choose the best candidates for this procedure.

To be eligible for this trial, participants must be 18 years or older and be candidates for the T-EUS procedure for any of the conditions mentioned. They also need to be able to give their consent to participate. The trial is currently recruiting patients, and it welcomes individuals of all genders. If you choose to participate, you can expect to be part of a study that aims to improve treatment options for people with these serious health issues.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • subjects candidate to therapeutic EUS (T-EUS) procedures for any underlying disease
  • 18 years old or older
  • able to provide an informed consent to inclusion.
  • Exclusion Criteria:
  • age \< 18 years
  • inability or unwillingness to sign the informed consent form (ICF)
  • contra-indication for endoscopy or use of fluoroscopy

About Paolo Giorgio Arcidiacono, Md

Dr. Paolo Giorgio Arcidiacono, MD, is a distinguished clinical trial sponsor with a robust background in medical research and patient care. With a commitment to advancing healthcare through innovative studies, Dr. Arcidiacono leads clinical trials that focus on developing effective treatments and therapies across various medical disciplines. His expertise in clinical methodologies and regulatory compliance ensures the highest standards of safety and efficacy in research. Driven by a passion for improving patient outcomes, Dr. Arcidiacono collaborates with multidisciplinary teams to foster scientific advancements and contribute to the broader medical community.

Locations

Milan, , Italy

Patients applied

0 patients applied

Trial Officials

Paolo Giorgio Arcidiacono, MD, FASGE

Principal Investigator

IRCCS San Raffaele Scientific Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials